CD68 and breast cancer: Several clinical studies performed on Chinese cohorts of patients with breast cancer demonstrated the association of increased stromal infiltration of CD68+ macrophages with larger tumor size, higher histological grade, hormone receptor negativity in BC patients (45, 65).